Health Care: Drugs

Celgene Corp (CELG: NASDAQ)

$104.53 1.76 | 1.71%
09/30/16 - 04:14 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 9.26B 7.67B 6.49B 5.51B
Cost of Sales 290.20M 270.60M 229.10M 210.18M
Gross Operating Profit 8.97B 7.40B 6.26B 5.30B
Selling, General, and Administrative Expenses 2.31B 2.03B 1.68B 1.37B
Research & Development 3.70B 2.43B 2.23B 1.72B
Operating Income before D & A (EBITDA) 2.96B 2.94B 2.35B 2.20B
Depreciation & Amortization 408.90M 373.60M 374.10M 283.45M
Interest Income 31.10M 28.20M 0.00 15.26M
Other Income - Net -251.20M -92.40M -223.00M -17.01M
Special Income / Charges 299.60M 48.70M 171.10M -168.95M
Total Income Before Interest Expenses (EBIT) 2.33B 2.50B 1.76B 1.74B
Interest Expense 310.60M 176.10M 91.60M 63.20M
Pre-Tax Income 2.02B 2.33B 1.67B 1.68B
Income Taxes 421.50M 327.50M 215.50M 225.31M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 1.60B 2.00B 1.45B 1.46B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 1.60B 2.00B 1.45B 1.46B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 1.60B 2.00B 1.45B 1.46B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.60B 2.00B 1.45B 1.63B
Preferred Dividends
Net Income Available To Common 1.60B 2.00B 1.45B 1.46B
Basic EPS from Continuing Ops. 2.02 2.49 1.75 1.69
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.02 2.49 1.75 1.69
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 2.02 2.49 1.75 1.69
Basic Normalized Net Income/Share 2.02 2.49 1.75 1.89
EPS fr Continuing Ops. 1.94 2.39 1.69 1.65
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.94 2.39 1.69 1.65
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.94 2.39 1.69 1.65
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.94 2.39 1.69 1.84
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with CELG

Latest CELG Headlines from TheStreet

More Financial News for CELG

Press Releases for CELG

See All Press Releases

Partner Headlines for CELG

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter